Align Technology Receives 510(k) Clearance From the FDA For Invisalign® Treatment With Mandibular Advancement in the U.S.
Align Technology, Inc. (NASDAQ: ALGN) today announced that the U.S. Food and Drug Administration (FDA) has cleared Invisalign treatment with mandibular advancement for commercial availability


